Written by Klarity Editorial Team
Published: Aug 21, 2026

Last updated: August 21, 2026
Thorazine (chlorpromazine) is a first-generation (typical) antipsychotic and the original phenothiazine used for schizophrenia, other psychotic disorders, manic symptoms in bipolar illness, severe pediatric behavior problems in selected cases, nausea and vomiting, intractable hiccups, preoperative apprehension, acute intermittent porphyria, and as an adjunct in tetanus. Brand Thorazine tablets are discontinued in many markets; generic chlorpromazine hydrochloride tablets remain widely available in 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg strengths. This guide covers how chlorpromazine works, label dosing ranges, boxed dementia-mortality and tardive dyskinesia warnings, anticholinergic and EPS risks, drug interactions, and when online psychiatry may support evaluation and oral follow-up.
See if online depression or mood care may be a fit →
Browse Klarity condition pages →
Chlorpromazine is a conventional (first-generation) antipsychotic in the phenothiazine class. According to MedlinePlus (last revised July 15, 2017), it treats symptoms of schizophrenia and other psychotic disorders, mania in bipolar disorder, severe behavior problems in children 1 to 12 years of age, nausea and vomiting, hiccups lasting one month or longer, restlessness before surgery, acute intermittent porphyria, and tetanus (with other medications). It works by changing the activity of certain natural substances in the brain and body. Brand names Promapar and Thorazine are marked discontinued on MedlinePlus; generic alternatives may be available.
Cleveland Clinic describes chlorpromazine as balancing dopamine to regulate mood, with additional uses for nausea, vomiting, prolonged hiccups, porphyria episodes, tetanus, and relaxation before a procedure.
The FDA label on DailyMed (chlorpromazine hydrochloride tablets, Amneal; updated December 29, 2023) classifies chlorpromazine as a dimethylamine derivative of phenothiazine with psychotropic, sedative, and antiemetic activity. It carries a boxed warning on increased mortality in elderly patients with dementia-related psychosis.
StatPearls (NCBI Bookshelf; last update May 16, 2023) frames chlorpromazine as a low-potency typical antipsychotic used for schizophrenia (especially positive symptoms), bipolar I manic episodes, acute agitation, nausea and vomiting, persistent singultus (chronic hiccups), preoperative apprehension, tetanus adjunct care, and acute intermittent porphyria.
NAMI lists chlorpromazine (Thorazine) among first-generation antipsychotics with higher tardive dyskinesia risk relative to many newer agents.
StatPearls states the precise mechanism is unknown, but the antipsychotic effect is believed to come from post-synaptic dopamine D2 blockade in the mesocortical pathway. D2 blockade in the nigrostriatal pathway helps explain extrapyramidal symptoms (EPS). Antiemetic effects come from combined blockade of histamine H1, dopamine D2, and muscarinic M1 receptors in the vomiting center.
DailyMed notes principal pharmacological actions are psychotropic, with sedative and antiemetic activity, strong antiadrenergic effects, weaker peripheral anticholinergic activity, and slight antihistaminic and antiserotonin activity. Low potency often means more sedation, orthostasis, and anticholinergic effects than high-potency first-generation drugs such as haloperidol (Haldol), while EPS risk remains clinically important.
MedlinePlus emphasizes that for schizophrenia or another psychotic disorder, chlorpromazine may control symptoms but does not cure the condition. Continue treatment as prescribed even when you feel better. Do not stop suddenly without a taper plan; abrupt stop can cause withdrawal symptoms such as nausea, vomiting, stomach pain, dizziness, and shakiness.
Per the DailyMed prescribing information, chlorpromazine hydrochloride tablets are indicated for:
StatPearls also notes off-label discussion of adjunct use in serotonin syndrome and migraine-associated nausea in some clinical settings. Off-label choices belong in a documented clinician relationship, not in a blog post alone.
DailyMed lists oral film-coated tablets containing 10 mg, 25 mg, 50 mg, 100 mg, or 200 mg of chlorpromazine hydrochloride. The label states that 100 mg and 200 mg tablets are for use only in severe neuropsychiatric conditions. Store at 20° to 25°C (68° to 77°F); protect from light and moisture.
StatPearls notes intramuscular and intravenous injection routes exist for acute control in clinical settings. Injection dosing and monitoring are clinic or hospital decisions. Oral tablets are the usual telehealth-relevant form for stable outpatient follow-up after a full evaluation.
MedlinePlus: chlorpromazine is usually taken two to four times a day for psychiatric use; every 4 to 6 hours as needed for nausea and vomiting; 2 to 3 hours before surgery for preoperative nervousness; and 3 to 4 times a day for up to 3 days for hiccups (switch therapy if hiccups continue after 3 days).
Always follow the dose on your prescription. DailyMed adult guidance includes:
StatPearls schizophrenia oral summary often cited in clinical teaching: initial about 25 to 75 mg/day in divided doses, maintenance around 200 mg/day, with a maximum oral total often discussed near 800 mg/day depending on setting and response. Your clinician sets the exact plan.
Pediatric oral dosing on DailyMed for selected behavioral uses is weight-based (for example about ¼ mg/lb every 4 to 6 hours as needed in outpatients). Chlorpromazine should generally not be used under 6 months of age except when potentially lifesaving. Pediatric dosing is specialist-driven.
After symptoms are controlled for a reasonable period, DailyMed directs gradual reduction to the lowest effective maintenance dose. Maximum improvement in psychosis may take weeks or months.
If you miss a scheduled dose, take it when you remember unless it is almost time for the next dose. Skip the missed dose rather than doubling up (MedlinePlus).
Do not stop suddenly. MedlinePlus and Cleveland Clinic both warn that abrupt stop can cause nausea, vomiting, dizziness, and related withdrawal symptoms. Ask your care team for a taper plan.
DailyMed boxed warning: elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of seventeen placebo-controlled trials (modal duration 10 weeks), largely with atypical antipsychotics, showed death risk about 1.6 to 1.7 times placebo. Over a typical 10-week trial, death rates were about 4.5% on drug versus about 2.6% on placebo. Most deaths appeared cardiovascular or infectious. Observational data suggest conventional antipsychotics may also increase mortality. Chlorpromazine hydrochloride is not approved for dementia-related psychosis.
MedlinePlus carries the same class warning and links to FDA safety information for antipsychotics in older adults with dementia.
DailyMed warns that tardive dyskinesia (TD), a syndrome of potentially irreversible involuntary dyskinetic movements, may develop with antipsychotic drugs. Risk and likelihood of irreversibility rise with duration and total cumulative dose, though TD can appear after relatively brief treatment at low doses. There is no known reliable way to predict who will develop TD at the start of therapy.
StatPearls lists EPS patterns that can appear from hours to days or longer:
Neuroleptic malignant syndrome (NMS) is a medical emergency. StatPearls describes lead-pipe rigidity, autonomic instability, high fever, altered mental status, leukocytosis, and elevated creatine kinase. MedlinePlus lists fever, muscle stiffness, confusion, fast or irregular heartbeat, and sweating among symptoms that need immediate medical contact.
DailyMed also notes that EPS from chlorpromazine can be confused with CNS signs of undiagnosed disease causing vomiting (for example Reye syndrome). Avoid chlorpromazine and other potential hepatotoxins in children and adolescents whose signs suggest Reye syndrome.
Common effects that may be bothersome (MedlinePlus / Cleveland Clinic) include dizziness, drowsiness, dry mouth, constipation, weight gain, increased appetite, restlessness, sleep trouble, nasal stuffiness, difficulty urinating, and sexual or menstrual changes related to prolactin.
Serious effects that need prompt care include yellowing of skin or eyes, signs of infection (fever, sore throat, chills), unusual bleeding or bruising, seizures, severe allergic reactions, vision changes (including night vision loss or brown-tinted vision), and uncontrolled movements.
StatPearls highlights additional low-potency class effects: orthostatic hypotension (especially with injection), QT prolongation risk, corneal deposits and lens opacity with prolonged use, cholestatic jaundice and liver injury, and hyperprolactinemia (galactorrhea, gynecomastia, menstrual changes, reduced libido). Regular eye exams are recommended on MedlinePlus because chlorpromazine may cause eye disease.
MedlinePlus precautions also cover sun sensitivity (use sunscreen and protective clothing), impaired heat regulation with vigorous exercise or extreme heat, drowsiness that can impair driving, and orthostasis when rising quickly, especially early in treatment and after the first dose.
DailyMed contraindications:
StatPearls adds caution with antihypertensives (severe hypotension risk), poorly controlled seizures, concurrent CNS depressants, and dopamine agonists such as levodopa (efficacy may be reduced). Cleveland Clinic lists conditions to disclose before use: dementia, glaucoma, heart disease or irregular rhythm, kidney or liver disease, low blood counts, low blood pressure, lung disease, Parkinson disease, seizures, urinary retention, pregnancy, and breastfeeding plans.
MedlinePlus: tell your clinician about asthma or emphysema, balance problems, breast cancer, pheochromocytoma, abnormal EEG history, bone marrow disorders, prior severe reactions to psychiatric medicines, and planned work with organophosphorus insecticides. If nausea treatment is the goal, report accompanying listlessness, confusion, seizures, severe headache, or focal neurologic symptoms, which may signal a condition that should not be treated with chlorpromazine alone.
Late pregnancy exposure may cause problems in newborns after delivery (MedlinePlus). Discuss pregnancy and breastfeeding plans with your clinician before starting or continuing therapy.
Cleveland Clinic lists examples of medicines that should not be combined with chlorpromazine in many cases (including certain QT-prolonging or interacting agents such as cisapride, dronedarone, levoketoconazole, metoclopramide, pimozide, saquinavir, thioridazine, ziprasidone, and quinidine) and notes broader interactions with alcohol, sedating antihistamines, benzodiazepines, opioids, anticholinergics, some seizure medicines, and other drugs that cause drowsiness or rhythm changes.
StatPearls notes extensive hepatic metabolism (including CYP1A2 and CYP2D6 pathways; CYP3A4 substrate discussion) with urine, bile, and fecal excretion, and half-life estimates often in the roughly 23 to 37 hour range for parent drug. Always give your clinician and pharmacist a full medication and supplement list, including alcohol use.
For myelogram procedures, MedlinePlus states clinicians often hold chlorpromazine for 2 days before and 1 day after the study. Tell surgical and dental teams you take this medicine.
Follow-up is not only about symptoms. Depending on dose, duration, and your history, clinicians may track:
StatPearls stresses interprofessional follow-up: psychiatry, primary care, pharmacy, and nursing coordination improve safety after initiation.
Online psychiatry through a network like Klarity (2,000+ licensed providers) may help with:
Telehealth does not replace emergency care for NMS, acute severe agitation with safety risk, overdose, uncontrolled vomiting with neurologic red flags, suspected Reye syndrome in a child, or new TD that needs urgent in-person assessment. Intramuscular or intravenous chlorpromazine is a clinic or hospital intervention. Dementia-related behavioral crises need specialized in-person pathways; chlorpromazine is not approved for dementia-related psychosis.
If you or someone near you is in crisis, call or text 988 (U.S. Suicide and Crisis Lifeline) or use local emergency services.
Generic chlorpromazine is often less expensive than many brand-only second-generation antipsychotics, but coverage still may vary by plan tier, prior authorization rules, and quantity limits. Klarity does not guarantee that any specific insurer will cover a visit or a prescription. Verify benefits before you book and before you fill. For condition-focused paths, start at Klarity condition pages or online depression and mood care.
Disclaimer: This article is for education only. It is not medical advice, a diagnosis, or a promise of coverage. Medication decisions require a licensed clinician who knows your history. Insurance benefits vary by plan; confirm coverage with your insurer and care team.
Yes. Thorazine was a brand name for chlorpromazine. MedlinePlus marks Thorazine as discontinued; generic chlorpromazine hydrochloride tablets remain available.
Yes. It is a conventional (typical) phenothiazine antipsychotic, often described as low potency compared with agents such as haloperidol.
Sedation or calming can appear early. Full antipsychotic benefit for psychosis may take weeks to months (DailyMed notes maximum improvement may not appear for weeks or even months). Follow your clinician’s timeline rather than stopping early when you feel partially better.
Some stable patients may receive oral therapy evaluation and follow-up online when state rules, clinical acuity, and monitoring needs allow. Acute IM dosing, emergency agitation, NMS, and many pediatric behavioral crises need in-person care. A Klarity clinician can help sort the right level of care.
Avoid alcohol unless your clinician approves it, because it can worsen side effects. Use caution with driving until you know how drowsy you become. Limit excess sun exposure, extreme heat, and sudden standing. Do not combine with other strong sedatives or interacting QT drugs without explicit clinician approval.
Both are first-generation antipsychotics. Chlorpromazine is lower potency with more anticholinergic, sedating, and orthostatic effects in many patients. Haloperidol is higher potency with a different EPS and QT profile and common use for Tourette tics. Choice depends on diagnosis, prior response, side-effect tolerance, and setting. See the Haldol guide for that agent’s label details.
Chlorpromazine (formerly Thorazine) remains a foundational first-generation antipsychotic with psychiatric and nonpsychiatric labeled uses, from schizophrenia and mania to nausea, intractable hiccups, and selected pediatric behavioral indications. Generic tablets span 10 mg to 200 mg, with higher strengths reserved for severe neuropsychiatric illness. Boxed dementia-mortality risk, TD, EPS, NMS, orthostasis, sun sensitivity, and drug interactions require careful monitoring. Online care can support education and stable oral follow-up for many adults, while emergencies and parenteral dosing stay in person.
Check whether online mood or depression care may fit your situation →
Find the right provider for your needs — select your state to find expert care near you.